Market Pulse 360°

Tweets ≠ financial advice. #DYODD. Affiliated w/ WallStWire Distribution Net. Disclaimers: Posts re subscribers marked #WallStWire

[Market Pulse 360° @MarketPulse360]

Tech now represents 39% of the S&P 500 - the highest ever, even surpassing the dot-com bubble. The difference? Earnings are actually strong this time around. But here's the catch: the market is running on fumes if these mega-cap leaders stumble. Broadcom's recent miss proved how fragile this concentration really is. $SPY https://t.co/l9QdpmBTEL

[Market Pulse 360° @MarketPulse360]

Broadcom beat earnings but the market's reaction tells a different story. Q3 AI chip guidance of $16B missed estimates by $1.2B. The bar was sky-high going in, and investors are now pricing in slower AI growth ahead. When the best-in-class chipmakers start guiding down, it's worth paying attention to what that means for the broader AI buildout.

$AVGO

https://t.co/bFn12N4qak

[Market Pulse 360° @MarketPulse360]

Roundhill Memory ETF Sets Price Record as Vera Rubin Confirms AI Memory Demand Is Structural

https://t.co/v3beINLmY1

[Market Pulse 360° @MarketPulse360]

The AI infrastructure play keeps rewarding believers. Marvell jumped 22% after Nvidia's Jensen Huang blessed their custom chips, while HPE crushed with record AI server demand. S&P 500 just broke 7,600 for the first time.

It's not hype when the fundamentals keep delivering. $MRVL

https://t.co/Ja1sNHFpOV

[Market Pulse 360° @MarketPulse360]

OpenAI launches new Codex tools for white-collar work

https://t.co/jIO9X6T3wR

[Market Pulse 360° @MarketPulse360]

Anthropic just filed for IPO, beating OpenAI to the punch. But here's what's more interesting: Jensen Huang just declared 'AI is now a profit generator.' Software stocks rallied hard on his message that agentic AI creates MORE tool demand, not less. The narrative is shifting from hype to actual business value. That's the real story. https://t.co/b5YW36KySF

[Market Pulse 360° @MarketPulse360]

Black founders raise highest amount of quarterly funding since 2022, but there’s a catch

https://t.co/WJraUrnz8T

[Market Pulse 360° @MarketPulse360]

The infrastructure play nobody's talking about enough: $DELL just posted 88% revenue growth with AI servers alone generating $16.1B in Q1. Stock up 100%+ in a month. When everyone's racing to build AI, someone has to build the actual servers. That's the real moat right now.

https://t.co/kauydgCMOB

[Market Pulse 360° @MarketPulse360]

Dell's AI server revenue just surpassed its PC business for the first time. $16.1B in AI servers vs $14.6B in PCs. That's the entire tech industry in one earnings report: the old guard is being consumed by the new. Stock up 32% on the day. The shift is real. $DELL

https://t.co/9WuWLzZ16m

[Market Pulse 360° @MarketPulse360]

The S&P 500's CAPE ratio just hit 42, matching dot-com bubble levels. Yet the market keeps climbing. The difference? Passive flows, mega-cap tech dominance, and currency debasement. History says returns should be negative next decade. But structural changes might rewrite the playbook.

https://t.co/WSo5ofMrc7

[Market Pulse 360° @MarketPulse360]

Lilly's $3.8B vaccine shopping spree is fascinating. A company printing money from GLP-1s is now betting big on infectious disease prevention. Shingles, EBV, antibiotic-resistant bacteria. It's not just about treating disease anymore, it's about preventing it at the source. Strategic pivot. $LLY

https://t.co/qhXKRWzLs9

[Market Pulse 360° @MarketPulse360]

The patent cliff is real. Big pharma has $1.3T in firepower. Biotech valuations recovered. Result? $84B in M&A deals in Q1 2026 alone, nearly 2x last year. IQVIA forecasts $140-160B for the full year. This isn't FOMO, it's capital deployment meeting structural necessity. The winners will be those who move with precision and speed. https://t.co/lQBYljuiuT

[Market Pulse 360° @MarketPulse360]

Lilly's $3.8B vaccine spree signals a quiet but profound shift in pharma strategy. Instead of chasing blockbuster treatments, they're betting big on prevention—shingles, resistant bacteria, EBV. When you've got GLP-1 cash flowing, you can afford to think differently about disease. $LLY https://t.co/HJYRrppPmA

[Market Pulse 360° @MarketPulse360]

The memory chip shortage is reshaping valuations. Micron just hit $1T market cap, SK Hynix followed. UBS tripled Micron's price target to $1,625, betting on structural AI demand shifts. When commodity inputs become bottlenecks, pricing power flows to suppliers. $MU

https://t.co/EBuZi1t2SD

[Market Pulse 360° @MarketPulse360]

Rivian will deliver the first R2 SUVs on June 9

https://t.co/RCjm7f8Pn6

[Market Pulse 360° @MarketPulse360]

Micron just hit $1T market cap. That's wild when you think about it: a memory chip maker is now worth more than Walmart. Says everything about where capital is flowing. AI infrastructure isn't a trend, it's the infrastructure. The real question: can they scale fast enough to meet demand?

https://t.co/8zfvjo5ow8

[Market Pulse 360° @MarketPulse360]

What ClickUp’s mass layoff tells us about the future of work

https://t.co/pxesiRuu2J

[Market Pulse 360° @MarketPulse360]

Novo just cleared a major hurdle in Europe with Wegovy pill approval. First oral weight-loss drug on the continent, beating Lilly to market. The obesity space is getting crowded fast, but convenience matters. Oral formulations could expand the addressable market beyond injectable users. $NVO https://t.co/Nx2Kz0UxoO

[Market Pulse 360° @MarketPulse360]

The pope’s AI encyclical isn’t really about AI

https://t.co/00gHC3r999

[Market Pulse 360° @MarketPulse360]

Big pharma is in full acquisition mode. Q1 2026 biotech M&A hit $84B, up from $44B a year ago. The paradox? Market turmoil usually kills deals, but patent cliffs are forcing $LLY and peers to move fast. When your blockbusters lose exclusivity in 2-3 years, waiting isn't an option. https://t.co/7tc8UoZ0QD